Example of conditiondefinition

{
  "resourceType" : "ConditionDefinition",
  "id" : "example",
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode" : "pc"
  }],
  "url" : "http://hl7.org/fhir/ConditionDefinition/example",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.25.1"
  }],
  "name" : "Hyperlipidemia",
  "title" : "Hyperlipidemia Status",
  "status" : "draft",
  "date" : "2019-05-26T10:44:00+10:00",
  "publisher" : "HL7 International / Patient Care",
  "contact" : [{
    "telecom" : [{
      "system" : "url",
      "value" : "http://www.hl7.org/Special/committees/patientcare"
    }]
  }],
  "description" : "Hyperlipidemia Status",
  "code" : {
    "coding" : [{
      "system" : "http://snomed.info/sct",
      "code" : "55822004",
      "display" : "Hyperlipidemia (disorder)"
    }]
  },
  "hasSeverity" : false,
  "hasBodySite" : false,
  "hasStage" : false,
  "definition" : ["https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"],
  "observation" : ["http://example.org/fhir/ObservationDefinition/lipid-panel",
  "http://example.org/fhir/ObservationDefinition/cholesterol",
  "http://example.org/fhir/ObservationDefinition/triglyceride",
  "http://example.org/fhir/ObservationDefinition/cholesterol-hdl",
  "http://example.org/fhir/ObservationDefinition/cholesterol-ldl"],
  "medication" : [{
    "code" : {
      "coding" : [{
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "203151",
        "display" : "fenoldopam mesylate"
      }],
      "text" : "Gemfibrozil"
    }
  }],
  "plan" : [{
    "reference" : {
      "reference" : "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"
    }
  }]
}